Systematic review / meta-analysis / 2019
Higher circulating TMAO levels were associated with an increased risk of diabetes.
In a meta-analysis of 12 clinical studies encompassing 15,314 participants, elevated circulating TMAO levels were linked to higher odds of diabetes (OR = 1.89). Individuals with diabetes exhibited higher plasma TMAO concentrations than those without (SMD: 0.36). In dose-response evaluation, every 5 μmol/L rise in plasma TMAO was associated with a 54% greater risk of diabetes (OR = 1.54).
- Study type
- Systematic review and dose-response meta-analysis
- Who was studied
- 15,314 participants across 12 clinical studies
- What was measured
- diabetes risk and plasma TMAO levels
THE PAPER
Gut microbe-generated metabolite trimethylamine N-oxide and the risk of diabetes: A systematic review and dose-response meta-analysis.
Zhuang R, Ge X, Han L, Yu P, Gong X, Meng Q, Zhang Y, Fan H, Zheng L, Liu Z, Zhou X. Obes Rev, 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.